Skip to main content
Cell Proliferation logoLink to Cell Proliferation
. 2010 Apr 28;43(3):275–286. doi: 10.1111/j.1365-2184.2010.00677.x

Expansion of mouse sertoli cells on microcarriers

B Shi 1, S Zhang 1, Y Wang 1, Y Zhuang 1, J Chu 1, S Zhang 1, X Shi 2, J Bi 3, M Guo 1
PMCID: PMC6496594  PMID: 20546245

Abstract

Background:  Sertoli cells (SCs) have been described as the ‘nurse cells’ of the testis whose primary function is to provide essential growth factors and create an appropriate environment for development of other cells [for example, germinal and nerve stem cells (NSCs), used here]. However, the greatest challenge at present is that it is difficult to obtain sufficient SCs of normal physiological function for cell transplantation and biological medicine, largely due to traditional static culture parameter difficult to be monitored and scaled up.

Objective:  Operational stirred culture conditions for in vitro expansion and differentiation of SCs need to be optimized for large‐scale culture.

Materials and methods:  In this study, the culturing process for primary SC expansion and maintaining lack of differentiation was optimized for the first time, by using microcarrier bead technology in spinner flask culture. Effects of various feeding/refreshing regimes, stirring speeds, seed inoculum levels of SCs, and concentrations of microcarrier used for expansion of mouse SCs were also explored. In addition, pH, osmotic pressure and metabolic variables including consumption rates of glucose, glutamine, amino acids, and formation rates of lactic acid and ammonia, were investigated in culture.

Results:  After 6 days, maximal cell densities achieved were 4.6 × 106 cells/ml for Cytodex‐1 in DMEM/FBS compared to 4.8 × 105 cells/ml in static culture. Improved expansion was achieved using an inoculum of 1 × 105 cells/ml and microcarrier concentration of 3 mg/ml at stirring speed of 30 rpm. Results indicated that medium replacement (50% changed everyday) resulted in supply of nutrients and removal of waste products inhibiting cell growth, that lead to maintenance of cultures in steady state for several days. These conditions favoured preservation of SCs in the undifferentiated state and significantly increased their physiological activity and trophic function, which were assessed by co‐culturing with NSCs and immunostaining.

Conclusion:  Data obtained in this study demonstrate the vast potential of this stirred culture system for efficient, reproducible and cost‐effective expansion of SCs in vitro. The system has advantages over static culture, which has major obstacles such as lower cell density, is time‐consuming and susceptible to contamination.

Introduction

Sertoli cells (SCs) are recognized as the ‘nurse cells’ of the testis whose function is to secrete essential growth factors, trophic factors, regulatory proteins and nutritive factors to create an appropriate environment for development of other cells (for example, germinal and nerve stem cells, as used here) (1). These factors include transforming growth factors (TGF‐α and β), insulin‐like growth factor I (IGF‐I), basic fibroblast growth factor (bFGF or FGF2) (2), platelet‐derived growth factor (PDGF) (3, 4) and neurturin (NTN) (5). SCs express cytokines such as interleukin‐1α (IL‐1α) and interleukin‐6 (IL‐6) that have also been shown to have trophic effects on dopaminergic neurons (6, 7). Trophic factors such as sulphated glycoproteins 1 (prosaposin) (8) and 2 (clusterin) (9), desert hedgehog (Dhh) (10) [a member of the Sonic hedgehog (Shh) family] is also produced by SCs, which seems to stimulate differentiation of dopaminergic neurons (11). Co‐culturing of SCs with foetal ventral mesencephalon (VM) has resulted in a remarkable increase in number of surviving TH‐positive neurons, and soma size and neuritic outgrowth were enhanced (12). Cameron and colleagues reported that 16‐to 19‐day‐old SCs enhanced survival of foetal neurons or cells of a human teratocarcinoma line hNT neurons, upon thawing, when exposed to conditioned media from SCs (13). Moreover, number of tyrosine hydroxylase (TH+) neurons of both rat and human ventral mesencephalic tissues, together with human neuroteratocarcinoma cells (hNT), were significantly higher when co‐cultured with SCs from 2‐month‐old pigs (14, 15). Furthermore, soma size and neurite outgrowth significantly increased in the co‐culture group compared to control cultures. When mouse SCs were transplanted alone (allograft) into the 6‐hydroxydopamine‐lesioned striatum (12), SCs survived and enhanced the rats’ behavioural recovery. Moreover, SCs promoted graft survival of co‐transplanted bovine adrenal chromaffin cells (xenografts) (16, 17, 18) in normal rat striatum.

Cell transplantation is a promising approach for restoration of function in neurodegenerative conditions such as Parkinson’s disease (PD). Neural transplantation in PD is to provide dopamine‐producing cells for the striatum to substitute those mesencephalic dopamine neurons that have been lost. The major obstacle to this approach is extensive cell death during isolation and grafting (19, 20, 21), co‐transplantation of Sertoli cells with therapeutic neurons is a promising way to overcome this (22, 23).

As SCs are only available in small numbers in the human body, it is necessary to optimize their culture process in vitro suspension to maximize primary population for cell transplantation or for other uses. Typically, multiplication of SCs is performed in two‐dimensional (2D) cultures or plastic tissue culture, which has serious drawbacks such as time consumption and susceptibility to contamination due to increased number of cell passages necessary, although there is limited availability of surface area and nutrients. Furthermore, culture conditions tend to be suboptimal due insufficient monitoring and control of culture (24). To expand SCs in a controlled reproducible and cost‐effective way, development of appropriate bioreactors could be an alternative option.

For development of a bioreactor system, it is important to understand the demands of the specific cells for optimal survival and expansion. Cell growth is inhibited by shortage of nutrients or by excess metabolites. To obtain optimal culture conditions, the feeding/refreshing regime is crucial (25, 26, 27), nutrients such as glucose, glutamine and other amino acids are consumed while, metabolites such as lactate and ammonia accumulate and are toxic to the cells. These could inhibit cell expansion at certain concentrations (28, 29, 30, 31). To prevent growth inhibition by metabolite production and/or nutrient deficiency, the feeding regime always needs to be optimal. Cell number expansion is correlated to nutrient consumption and metabolite production, so cell proliferation can be monitored in the bioreactor indirectly by monitoring metabolism (27, 32, 33). To date, investigation of metabolism related growth of SCs in a microcarrier bead‐based culture system has, to the best of our knowledge, not been published. The main aim of this investigation has been to optimize the culture process of primary SCs by microcarrier technology in spinner flask culture and to evaluate effects of various feeding/refreshing regimes, stirring speeds and inoculation concentrations on expansion of mouse SCs. In addition, SCs have been co‐cultured with neural stem cells (NSCs) to test nutritional functions of SCs after microcarrier culture.

Materials and methods

Sertoli cell isolation

ICR mice were purchased from the BIKAI experimental animal center (Shanghai, China) and maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Sertoli cells were isolated from the mice at 12 days according to the method of Steinberger, with some modifications (34). Briefly, testes were decapsulated, minced and rinsed twice in phosphate‐buffered saline (PBS), then digested with 0.25% trypsin and 0.1% collagenase‐1(1:1) (Sigma, St. Louis, MO, USA) at 31 °C for 30 min. Isolated testicular fragments were centrifuged at 99 g for 10 minutes and washed twice with DMEM supplemented with 10% foetal bovine serum (FBS; Gibco, Grand Island, NY, USA) to terminate digestion and fragments were filtered through a 200‐mesh stainless steel filter. Cells were collected by centrifugation, supernatant was discarded and the collected cell pellet was resuspended in DMEM supplemented with 10% FBS, 1.5 g/l NaHCO3 (Lingfeng, CA, China), 100 U/ml penicillin (Invitrogen, Carlsbad, CA, USA) and 100 μg/ml streptomycin (Invitrogen). Finally, the dispersed cells were seeded into culture flasks and maintained in a humidified atmosphere of 95% air and 5% CO2 at 37 °C for 10 min; cell culture fluid was transferred to other flasks to remove spermatogenic cells. Sertoli cells attached to the bottom of T‐flasks 2 days later, and the supernatant was discarded. Then the purified Sertoli cells quickly spread to form a monolayer in the new medium. When cells on surfaces of T‐flasks were nearing confluence, they were washed in PBS and enzymatically harvested using 0.25% trypsin in 1 mm EDTA solution (Invitrogen), followed by replating at 500 cells/cm2 (passage 1).

Monolayer pre‐culture

The SCs were plated at 2500 cells/cm2 in DMEM proliferation medium which was replaced once every 3 days. At near‐confluence, cells were subcultured to passage 3 as described above. Harvested passage 3 cells were used for 3D microcarrier bead culture in spinner flasks.

Microcarrier culture in spinner flask

For stirred microcarrier bead cultures, 100 ml spinner flasks (Bellco Glass Inc., Vineland, NJ, USA; model #1965) were used with final medium volume of 80 ml and stirring speed of 20, 30 and 40 rpm respectively. Spinner flasks were siliconized before use with Sigmacote (Sigma) and in which SCs were also cultured in a humidified atmosphere of 95% air and 5% CO2 at 37 °C.

Required quantities of Cytodex‐1 were weighed (final concentrations 1.0, 3.0 and 5.0 mg/ml, respectively), hydrated and sterilized by autoclaving, as recommended by the manufacturers. Microcarriers were equilibrated in serum‐free culture medium for at least 30 min prior to cell addition, to maximize cell attachment. Cells were inoculated on to microcarrier beads at 50% the final volume. Intermittent stirring (3 min every 1 h) was carried out for 6 h. After this, volume was increased to 75% and intermittent stirring was performed for another 6 h. Finally, volume of medium in the spinner was increased to 100% and constant stirring speed was initiated. During the culture period, 50% fresh medium was replaced every day starting from day 2, that is microcarriers were allowed to settle for 10 min, 50% supernatant was discarded and new medium was added.

Sampling

Spinner flasks were removed from the incubator and placed in a laminar flow hood. Agitation was interrupted and at 24‐h intervals and samples were collected immediately to minimize variation occurring as a result of sedimentation of microcarriers. Then, collected samples were stored at −20 °C for prospective analysis of glucose, lactic acid, amino acids and ammonium in the medium; pH and osmotic pressure were also measured.

Cell number and viability

Cell density was determined using a haemocytometer and viability was assayed using standard trypan blue dye exclusion. For sample preparation, microcarriers attached to cells were washed twice in PBS followed by trypsin (0.25%) (v/v) addition, then incubated for 3 min in a 37 °C water bath. Occasional flicking was performed to facilitate detachment of cells from the beads. DMEM with 10% foetal bovine serum was added to stop trypsinization and supernatant with cells was collected into new tubes. Beads were washed twice to detach remaining cells and supernatants were pooled. Cells were centrifuged and suspended in fresh medium. Samples were then taken for counting and cell staining. Each experiment was performed in triplicate.

Measurement of metabolite in media

Supernatant samples were collected throughout the experiments, centrifuged for 10 min at 197 g and stored at −20 °C for subsequent analysis. Samples were treated according to instructions provided on the assay kit before analysis and glucose, l‐glutamine, lactate and ammonia concentrations were measured using the kit (Jiancheng Technology, Nanjing, China). Amino acid concentrations were measured using methods for quantitation of amino acids with O‐phenyl isothiocyanate (OPA, Fluka, Swizterland). Resulting phenylthiocarbamyl derivatives were assayed by reverse‐phase high‐performance liquid chromatography (HPLC) (HP1100; Hewlett Packard, Waldbronn, Germany).

Estimation of specific growth rate and rate of metabolite formation

Specific growth rate (μ) was calculated by plotting logarithm of viable cell density versus culture time during exponential growth phase based on eqn (1):

graphic file with name CPR-43-275-e001.jpg (1)

where t is culture time (days), C t is viable cell density (cells/ml) at time t and C 0 is inoculation concentration.

Specific consumption or production rates of glucose (q Glc), l‐glutamine (q Gln), lactate (q Lac) and ammonia (q Amm) were calculated according to (2), (3) based on data collected during growth phase and evaluated from plotting substrate and product concentrations against integrated viable cell density.

graphic file with name CPR-43-275-e002.jpg (2)
graphic file with name CPR-43-275-e003.jpg (3)

where C is viable cell density (cells/ml), S is substrate concentration, P is product concentration and t is time (days).

Lactate yield on glucose consumed (Y lactate/glucose, mmol/mmol) was calculated by dividing specific lactate production rate by specific glucose consumption rate. Yield (Y ammonia/glutamine, mmol/mmol) was calculated by dividing specific production rate (ammonia) by specific consumption rate (l‐glutamine).

Neuronal stem cell isolation and culture

Primary neuronal cultures derived from day 14 mouse embryos (E14) were performed as previously described, with some modifications (Daadi et al., 1999). In brief, dorsal‐most aspect of medial and lateral ganglionic eminences, cortex and mesencephalon were dissected and mechanically dissociated (separately) using a fire‐polished Pasteur pipette in DMEM/F12 (1:1) medium supplemented with 10% FBS. Cells were plated at density 106 cells/ml on poly‐l‐ornithine‐coated (15 mg/ml; Sigma) glass coverslips in 24‐well Nunclon culture dishes at 0.5 ml/well. Under these culture conditions, 98% of cells exhibited neuronal morphology [for detailed description of the bioassay, see Daadi et al. (1999)]. In cultures maintained for 1 week, half cell culture medium was replaced after 3 and 5 days in vitro (DIV), and incubated at 37 °C in 95% air/5% CO2 humidified atmosphere.

Cell co‐culture procedures

NSCs, NSCs + SCs2D (obtained from two‐dimensional culture) and NSCs + SCs3D (obtained from microcarrier culture) were seeded at density of 200 000 cells/cm2 on poly‐l‐lysine coated six‐well chamber slides (10 μl/ml; Sigma) in DMEM with 10% FBS and 50 μg/ml gentamicin (Sigma). In the co‐culture, cells were plated 1:1 and plating density was maintained at 200 000 cells/cm2. After 24‐h incubation, media changes (50%) were performed each day. Cells were then incubated at 37 °C in a 95% air/5% CO2 humidified atmosphere.

Microscope observation

Cell expansion on control plates and on Cytodex‐1 was observed on a daily basis using an inverted microscope. Samples of microcarrier beads were taken on days 2, 4, 6 and 8 and incubated at 37 °C for 45 min with MTT (3(4,5‐dimethylthiazol‐2‐yl)‐2,5‐ diphenyltetrazolium bromide; Sigma) to assess metabolic activity. MTT, a soluble yellow salt, is converted by mitochondria into insoluble purple formazan salt. Meanwhile, samples of microcarriers were checked daily using a scanning electron microscope (SEM).

Immunohistochemistry

To identify SCs and NSCs, immunohistochemistry was performed using a Fas‐L staining kit (Boshide Technology, Wuhan, China); NSCs were identified using a nestin immunofluorescence kit (Boshide Technology). Cells were processed and stained according manufacturers instructions.

Results

Effects of stirring speed and inoculum on cell expansion

Viscosity of fresh culture media with 3 mg/ml Cytodex‐1 at 37 °C was determined using a Couette viscometer (Brookfield, Stoughton, MA, USA). Media were found to be Newtonian fluids with viscosity of approximately 1cPa. Specific density of fresh media was determined using a balance and graduated cylinder, and found to be approximately 1.01. Rheology of media in the spinner was simulated by computational fluid dynamic (CFD) (ANSYS ICEM CFD10.0, UK) at stirring speed of 20, 30 and 40 rpm, respectively. Corresponding shear stresses(τ) were 0.8025, 1.3402 and 1.8025 Pa. Samples of microcarriers were checked using an inverted microscope on day 2, and it was observed that the majority of SCs had successfully attached to microcarriers at stirring speed of 30 rpm, resulting in almost all beads being covered by cells in the spinner; however, only 40% of cells attached to microcarrier beads at stirring speed of 20 rpm, and almost 10% of microcarrier beads were crushed by the impeller at rotation rate of 40 rpm (shown in Fig. 1).

Figure 1.

Figure 1

Microscopic observation of Sertoli cells (SCs) grown at different stirring speeds in spinner flask culture. SCs plated at 1 × 105 cells/ml in 80 ml of DMEM in the presence of 3 mg Cytodex‐1 per ml at the stirring speed of 20, 30 and 40 rpm.

Effect of inoculum on expansion of SCs was investigated by performing control experiments in both six‐well plates and in spinner flasks. Cells were seeded at three different concentrations, 0.5 × 105, 1 × 105 and 2 × 105 cells/ml in spinners with microcarrier Cytodex‐1 concentration of 3 mg/ml and six‐well plates respectively. Viable cell densities, in terms of cells per ml, and viabilities were obtained by three independent runs; this indicated that maximum density of SCs grown in spinner flasks with microcarrier reached 4.6 × 106 cells/ml, which was approximately 10 times that of controls. Cells grown in spinner flasks consistently showed high viabilities (above 90%), while with those on control plates an increase in cell death was observed (viabilities decreased as far as 80% at some points) (Fig. 2).

Figure 2.

Figure 2

Effect of inoculum on viable cell density of Sertoli cells (SCs). Effect of inoculum on viable cell density for SCs grown in: (a) stirred microcarrier cultures and (b) control plates. Cells were plated at () 0.5 × 105, (•) 1 × 105 and () 2 × 105 cells/ml in 80 or 2.5 ml of DMEM, for the stirred and control cultures, respectively. For stirred cultures, 3 mg of Cytodex‐1 per mL was used. □, ○, △ stand for viabilities (%) of SCs, plated at () 0.5 × 105, (•) 1 × 105 and () 2 × 105 cells/ml in the figure. Media (50%) was changed every day from day 2.

Typically after seeding, cells exhibited classical expansion trends consisting of death or lag phase in the first 24 h followed by an exponential phase leading to maximum cell density of 11.5–45.8 × 105 cells/ml in stirred microcarrier cultures and 4.5–4.8 × 105 cells/ml on control plates. For inocula of 0.5 × 105, 1 × 105 and 2 × 105 cells/ml, 23‐, 44.6‐ and 22.7‐fold increases respectively were obtained from stirred microcarrier cultures, while increases were significantly lower (9‐, 4.6‐ and 2.4‐fold) on control plates. Interestingly, maximum cell number per cm2 in stirred microcarrier culture was also higher than that of control plates (3.38 versus 1.84 × 105 cells/ml), as SCs grow layer by layer on microcarriers compared to those on control plates (Table 1).

Table 1.

 Initial and final cell densities, and fold increase of Sertoli cells grown in stirred microcarrier cultures and six‐well control plates

Culture type Initial cell density Cells per bead Final cell density Fold increase
105 cells/ml 105 cells/cm2 105 cells/ml 105 cells/cm2
Stirred microcarrier cultures 0.5 0.039 4 11.5 ± 1.0 0.87 ± 0.075 23
1.0* 0.078* 8* 44.6 ± 3.7* 3.38 ± 0.28* 44.6*
2 0.156 16 45.4 ± 4.1 3.44 ± 0.31 22.7
Control plates 0.5 0.13 4.5 ± 0.48 1. 80 ± 0.128 9
1 0.26 4.6 ± 0.53 1.84 ± 0.192 4.6
2 0.52 4.8 ± 0.53 1.86 ± 0.212 2.4

For stirred cultures, 3 mg of Cytodex‐1 per ml was used for the different inocula. Values denoted with an asterisk (*) obtained when using inoculum of 1.0 × 105 cells/ml. All experiments were averages of three independent runs (Inline graphic ± S, n = 3).

The death or lag phase occurred within the first 24 h, due to decrease in cell number caused by adaptation of cells to the culture system. This drop in cell density was more pronounced in stirred cultures possibly because of poor microcarrier colonization and agitation of unattached cells, which in turn were a result of shear stress to cells. The exponential phase continued for an extended time period for stirred cultures (5–6 days for stirred culture versus 2–3 days for six‐well plate cultures), yielding higher final cell densities (11.5–45.8 × 105 cells/ml from stirred culture versus 4.5–4.8 × 105 cells/ml from six‐well plate cultures); this was probably due to greater available surface area available compared to control plates (Table 2) .

Table 2.

 Available surface areas estimated in for stirred microcarrier bead cultures and control plates

Culture type Cytodex‐1 concentration Media (ml) Total available area (cm2)
mg/ml cm2/ml
Stirred microcarrier culture 1 4.4 80 352
3 13.2 80 1056
5 22 80 1760
Control plates 3.84 2.5 9.6

Maximum specific growth rates were estimated from slope of growth curves during the exponential phase (Table 3). Interestingly, calculated maximum growth rates (approximately 0.029 h−1) were very similar in stirred cultures and the plate cultures (Table 3), indicating that shear stress was not one of the crucial factors affecting cell expansion in the spinner flasks (36, 37, 38).

Table 3.

 Apparent (μ app) and maximum (μ max) specific growth rates calculated using first order kinetic model for Sertoli cells (SCs) grown in stirred microcarrier cultures and control plates.

Culture type Initial cell density (105 cells/ml) Apparent growth rate (μ app) (h−1) Maximum growth rate (μ max) (h−1)
Stirred microcarrier culture 0.5 0.022 ± 0.001 0.028 ± 0.001
1 0.026 ± 0.0012 0.029 ± 0.002
2 0.022 ± 0.0009 0.026 ± 0.0011
Control plates 0.5 0.017 ± 0.0008 0.023 ± 0.0013
1 0.027 ± 0.0013 0.03 ± 0.002
2 0.028 ± 0.0014 0.031 ± 0.0021

In stirred cultures, 3 mg of Cytodex‐1 per ml was used for the different inocula. Maximum specific growth rates (μ max, h−1) and apparent specific growth rate (μ app, h−1) estimated using first order kinetic model for cell expansion and death applied to slope of curves during exponential phase. All experiments were averages of three independent runs, represented as (Inline graphic ± S, n = 3).

During cell culture, activity of the enzyme lactate dehydrogenase (LDH), normally used to characterize viability status of the culture (39), was also detected. In this case, LDH levels were all below 21 U/l (data not shown), which is in accordance with percentage low cell death observed in stirred cultures. In particular, LDH level for inoculum 1.0 × 105 cells/ml was lowest (15 U/l). Inoculum 1.0 × 105 cells/ml was optimal, taking into account inoculum maximum cell density and fold increase in cell population.

Effect of microcarrier bead concentration on cell expansion

Maximum cell density achieved in microcarrier culture not only depended on adequate culture conditions but also on available surface area for cell population growth (40). Based on recommended concentrations of Cytodex‐1 ranging from 0.5 to 5 mg/ml final volume, 1.0 × 105 cells/ml were inoculated with different microcarrier bead concentrations of 1, 3 and 5 mg/ml, respectively. Microscopic observation of cultures showed highest cell density of 45.8 × 105 cells/ml, which was achieved with micromarrier concentration of 3 mg/ml with inoculum of 1.0 × 105 cells/ml. However, there were very many empty beads at concentration of 5 mg/ml; even by end of the experiments, when cells reached the plateau stage, and final achieved cell density was only 41.2 × 105 cells/ml. At microcarrier concentration of 1 mg/ml, no empty beads were observed in the medium, but final cell density was very low (21.5 × 105 cells/ml) (Fig. 3). This indicated that there was insufficient surface area for attachment of SCs at 1 mg/ml Cytodex‐1 concentration, whereas excess surface area for increase in number of SCs was available at 5 mg/ml Cytodex‐1 concentration.

Figure 3.

Figure 3

Microscopic observation of Sertoli cells grown at different microcarrier concentrations. Sertoli cells (SCs) plated at 1 × 105 cells/ml in 80 ml of DMEM with different microcarrier bead concentrations, observed on the 2nd day after inoculation.

Metabolic characterization of SCs in stirred cultures

Concentration of glucose, glutamine, lactate and ammonia as well as their consumption or production rates, throughout the culture, is depicted in Fig. 4. In general, medium replacement was efficient in supplying nutrients (glucose and glutamine). Indeed, in our experiments, glucose and glutamine concentrations did not decrease to 15 and 1 mm, respectively. Moreover, maximal lactate concentration was 13.4 mm during the culture process, which was far lower than 20 mm. It has been reported that population growth of haematopoietic cells and further mammalian cells were inhibited when lactate concentration was above 20 mm (41, 42). Ammonia is also detrimental to well‐being of cells, being an order of magnitude more toxic than lactate. In this study, ammonia concentration was higher than 4 mm after 7 days culture, which may have been the main factor leading SCs entering a stable phase. Similarly, it has also been reported that ammonia accumulation inhibited cell expansion when its concentration was above 4 mm (41). Overall apparent yields of lactate from glucose (Y lact./gluc.) and ammonia from glutamine (Y ammo/gln) were calculated. Y lact./gluc provides an estimate of the fraction of glucose converted to lactate by glycolysis (43); mean Y lact/gluc was 1.65 mollac/molgluc and calculated Y ammo/gln was 1.39 molammo/molgln.

Figure 4.

Figure 4

Substrate concentration and metabolite profiles during culture of Sertoli cells (SCs) on Cytodex‐1 microcarrier beads. Concentration (, •, , ) and specific production/consumption (□, ○, △, ▽) rates of glucose (a), lactate (b), glutamine (c) and ammonia (d) in culture represented. Values displayed represent average of three independent experiments. Error bars indicate the standard deviation of duplicate cultures. SCs (1 × 105 cells/ml) cultured with microcarrier bead concentration of 3 mg/ml. Media (50%) was changed every day, starting on day 2.

Concentrations of amino acids in the medium were measured, and there were no obvious changes in their concentrations apart from glutamate and alanine (data not shown). Final concentrations of glutamate and alanine were 0.56 and 1.12 mm respectively. pH and osmotic pressure of media were also determined. Variation in pH was in the range of 6.8–7.2, and the range of osmotic pressure values was 305–320 mOsm/kg.

Visualization of SCs using optical microscopy and scanning electron microscopy

SCs grown on microcarrier beads in spinner flasks were visualized with MTT staining, using an optical microscope and also were visualized using a scanning electron microscope (SEM) at 2‐day intervals. Gradual increase in microcarrier occupancy by SCs was observed and cells remained viable and metabolically active in culture (Fig. 5). In general, successful cell adhesion of SCs to microcarriers was achieved after 2 days of culture (Fig. 5a,e); at day 4, number of viable cells on beads significantly increased and some microcarrier aggregation was observed (Fig. 5b,f). At days 6 and 8, a high percentage of beads was totally covered by SCs and intense microcarrier aggregation became more evident (Fig. 5c,d,g,h, respectively).

Figure 5.

Figure 5

Optical and scanning electron micrographs of Sertoli cells (SCs) cultured on microcarrier beads under stirred culture conditions. SCs visualized using an optical microscope, day 2 (a), day 4 (b), day 6 (c) and day 8 (d) after MTT staining (200× amplification) for Cytodex‐1, respectively. SCs visualized using a scanning electron microscope, day 2 (e), day 4 (f), day 6 (g) and day 8 (h).

Identification of SCs by immunocytochemistry

SCs cultured both on control plates and in stirred culture conditions were identified by immunocytochemical reaction labelled with anti‐Fas‐L antibody. Strongly positive expression Fas‐L in cytoplasm was observed when SCs were cultured with both culture conditions, but expression of Fas‐L was absent in negative control cells (Fig. 6), indicating that SCs obtained from microcarrier culture were undifferentiated and had strong physiological activity.

Figure 6.

Figure 6

Identification of Sertoli cells (SCs) using immunocytochemistry with anti‐FAS‐L antibody. (a) SCs cultured on control plates. (b) Sertoli cells (SCs) cultured in stirred spinner flasks.

Co‐culture of SCs with neuronal stem cells

To explore bioactivity/biofunction of SCs cultured in spinner flasks, co‐culture of SCs with NSCs was performed. When NSCs were cultured alone, they tended to remain in small groups with a few scattered individual neurons; no neurite outgrowth was observed (Fig. 7a). In co‐cultures of SCs with NSCs from the same isolation group however, the NSCs dispersed over the culture plate in close proximity to the SCs; extensive neurite outgrowths were observed in co‐cultures where long neurites connected neighbouring individual cells and groups of cells (Fig. 7b,c). In particular, size of NSCs increased significantly; number of neurite outgrowth was highest in stirred culture conditions in all tested modes; This indicated that NSCs in 3D co‐culture systems have strongest physiological activity and pottential biofunction. Meanwhile, neurospheres were identified by nestin antibody immunofluorescence staining. Results revealed that no neurospheres were observed on control plate; however, a mass of neurospheres appeared 5 days after inoculation in co‐culture systems (Fig. 8b,c). It was clear that the number of neurospheres in NSCs + SCs3D group was greater than from NSCs + SCs2D group (Table 4), and number of cells gradually declined in the latter case.

Figure 7.

Figure 7

Photomicrograph of neuronal stem cells (NSCs) cultured alone and NSCs co‐cultured with Sertoli cells (SCs). (a) NSCs cultured in six‐well chamber slides. (b) NSCs co‐cultured with SCs obtained from two‐dimensional culture. (c) NSCs co‐cultured with SCs obtained from microcarrier bead suspension culture. All photographed on day 3 after inoculation (the scale bar is 5 μm). Neurite outgrowth was marked with.

Figure 8.

Figure 8

Nerve stem cells (NSCs) immunocytofluorescently labelled with anti‐nestin antibody to identify neurospheres (day 6). (a) NSCs cultured on six‐well chamber slides. (b) NSCs cultured with Sertoli cells (SCs) obtained from two‐dimensional culture. (c) NSCs cultured with SCs obtained from microcarrier bead culture.

Table 4.

 Distribution of the number of neurospheres in different co‐culture systems

Days The number of neurospheres
NSCs + SCs2D* NSCs + SCs3D**
 6 22 ± 0.54 34 ± 0.39
10 20 ± 0.34 33 ± 0.27
14 19 ± 0.59 36 ± 0.49
18 13 ± 0.44 35 ± 0.51

All experiments were averages of three independent runs, represented as (Inline graphic ± S, n = 3).

*Neuronal stem cells (NSCs) co‐cultured with Sertoli cells (SCs), obtained from two‐dimensional cultivation.

**Neuronal stem cells (NSCs) co‐cultured with Sertoli cells (SCs), obtained after microcarrier culture.

Discussion

Co‐transplanting SCs with grafts (cells or tissue) could be an ideal way to enhance graft survival, by delivering an appropriate biological cocktail of trophic and immunosuppressant factors. Currently, the requirement for large numbers of SCs for research and therapeutic applications is evident. Static cultures have several drawbacks (for example, concentration gradients, difficult monitoring and control) that can be alleviated by using suspension culture systems such as in stirred bioreactors (44). Thus, population growth of these cells can constitute an increasingly important bioprocess with scaling‐up feasibility. Use of stirred bioreactors facilitates expansion of cells under controlled conditions and the 3D microcarrier bead system offers advantages in terms of cell yield, compared to conventional cultures on plates. For expansion of SCs, no previous report has been published regarding use of a stirred system. As SCs are usually expanded as anchorage‐dependent cells, they require support and microcarrier beads appear to be a promising solution. Cytodex‐1 (GE Healthcare, Milwaukee, USA), a microporous microcarrier made up of a dextran matrix with a collagen layer at the surface, has been successfully used for expansion of primary cells as well as established cell lines [Amersham Biosciences, Baie d'Urfé, Quebec, Canada; (43, 45)]. One gram dry weight of this support has an approximate surface area of 4400 cm2 (Microcarrier Cell Culture Technology, GE Healthcare, Milwaukee, USA). Thus, Cytodex‐1 microcarriers were used in this study and the effect of several culture parameters was analysed. Its ability to support population growth of SCs in spinner flasks was investigated here. Improved cell number expansion was obtained using an inoculum of 1 × 105 cells/ml, 3 mg of Cytodex‐1 per ml, and agitation rate of 30 rpm, leading to maximum cell density of 2.1–4.6 × 106 cells/ml. Therefore, stirred culture appeared to be a promising system for expansion of SCs. Such similar culture systems have also been used for the expansion of bone marrow mononuclear cells (46), human natural killer cells (47), haematopoietic progenitor cells (48, 49), neural stem cells (50), mammary epithelial stem cells (38), primary brain astrocytes (43) and human embryoid bodies (51, 52).

Comparison of maximum proliferation rates in static and microcarrier suspension cultures can be used to evaluate effects of shear stress caused by impeller rotation. Results indicate that maximum growth rates were similar, indicating that shear stress was not affecting cell population growth in the spinner flasks, which was further confirmed by estimating maximum shear stress (τmax), assuming that τmax was 1.342 Pa. Maximum shear stress values of 1.5–3.0 Pa have previously been reported to cause damage to cells attached to such surfaces (53).

In addition, SCs exhibited typical growth curves in spinner flask cultures with microcarrier beads, which was characterized by a short death or lag phase, followed by exponential and stationary phases. In other mammalian cell cultures, as well as in microbial growth, a subsequent death phase is usually observed when medium change is not able to provide nutrients and remove toxic metabolic byproducts. As a preliminary study to assess whether chosen media renewal was necessary and would be sufficient to sustain cell needs, batch experiments were also performed (data not shown). For this purpose, cells were grown over 8 days with no medium change, both in spinner flasks and on the control plates. Contrary to results from re‐feed assays (50% medium changed everyday, starting on day 2), of batch experiments, the exponential phase was followed by a marked death phase. This phenomenon could be ascribed to average lower final maximum cell densities (2.68 × 106 cells/ml), indicating that medium renewal is required to maximize cell population growth, and in this case, the chosen re‐feeding system was sufficient to provide adequate culture conditions. However, it has been shown that concentration of glucose at 18.34 mmol/l and concentration of glutamine at 1.12 mmol/l, far lower than limited concentration (54, 55, 56)). This indicates that there is need for further feeding protocols or design of the new media. For example, dilution‐feeding protocols have been reported to increase extent of total cell expansion for cultures of umbilical cord blood cells and mobilized peripheral blood mononuclear cells in stirred and static conditions (49, 57).

Testing physiological activity and functional maintenance of Sertoli cells cultured by this newly developed stirred culture system is essential. Morphological analysis and biochemical monitoring of the cells grown on the microcarrier beads indicate that optimized conditions are able to sustain physiological activity of the SCs. It is surprising that nutritional function of SCs enhanced through culturing them under the microcarrier culture system, was identified for co‐culturing with NSCs.

In conclusion, in this study, we have successfully optimized the culture process for primary SCs by microcarrier technology in spinner flasks and obtained highly purified cell populations of undifferentiated cells. Viable cell concentration of SCs improved from 4.8 × 105 cells/ml in static culture to 4.6 × 106 cells/ml with normal physiological function. These SCs were also successfully co‐cultured with neuronal stem cells in vitro and significantly promoted nerve cell growth. This study demonstrates the vast potential of stirred culture systems for efficient, reproducible, and cost‐effective expansion of SCs in vitro suspension culture. This culture system has advantages over static culture (which has major obstacles such as lower cell density achieved, is time‐consuming and susceptibility to contamination). In this study, we overcame the major obstacle of obtaining sufficient SCs with normal physiological function for cell transplantation. For SCs to proceed into clinical trials for treatment of neurodegenerative diseases (for example Parkinson’s disease and Huntington’s disease), further investigation is needed to characterize trophic factor secretion by SCs during postnatal development and within transplants. On the other hand, maximal passage number of primary SCs is usually not more than 15, and quantities of bioactive factors secreted by primary SCs is lower than 0.1 g/l. To overcome these drawbacks, it is important to establish and develop immortalized and high‐level protein‐producing cell lines.

Acknowledgements

This study was supported by the National High Technology Research & Development Program (863 Program) of China (No. 2007AA02Z216), the National Special Fund for State Key Laboratory of Bioreactor Engineering (No. 2060204) and National Basic Research Program of China (No. 2007CB714303).

References

  • 1. Fawcett DW (1975) In: Hamilton DW, Grup RD, eds. Handbook of Physiology: Male Reproductive System, Vol. 5, pp. 21–56, Washington, DC: American Physiological Society. [Google Scholar]
  • 2. Skinner MK 1993. Secretion of growth factors and other regulatory factors In: Russell LA, Griswold MD, eds. The Sertoli Cell, pp. 237–248. Clearwater: Cache River Press. [Google Scholar]
  • 3. Loveland KL, Zlatic K, Stein‐Oakley A, Risbridger G, DeKretser DM (1995) Platelet‐derived growth factor ligand and receptor subunit mRNA in the Sertoli and Leydig cells of the rat testis. Mol. Cell. Endocrinol. 108, 155–159. [DOI] [PubMed] [Google Scholar]
  • 4. Selawry HP, Cameron DF (1993) Sertoli cell‐enriched fractions in successful islet cell transplantation. Cell Transplant. 2, 123–129. [DOI] [PubMed] [Google Scholar]
  • 5. Widenfalk J, Nosrat C, Tomac A, Westphal H, Hoffer B, Olson L (1997) Neurturin and glial cell line‐derived neurotrophic factor receptor‐beta (GDNFR‐beta), novel proteins related to GDNF and GDNFR‐alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J. Neurosci. 17, 8506–8519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Ling ZD, Potter ED, Lipton JW, Carvey PM (1998) Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neurol. 149, 411–423. [DOI] [PubMed] [Google Scholar]
  • 7. Von Coelln R, Unsicker K, Krieglstein K (1995) Screening of interleukins for survival‐promoting effects on cultivated mesencephalic dopaminergic neurons from embryonic rat brain. Brain Res. Dev. 89, 150–154. [DOI] [PubMed] [Google Scholar]
  • 8. Morales CR, El‐Alfy M, Zhao Q, Igdoura S (1995) Molecular role of sulfated glycoprotein‐1 (SGP‐1/prosaposin) in Sertoli cells. Histol. Histopathol. 10, 1023–1034. [PubMed] [Google Scholar]
  • 9. Griswold MD, Morales C, Sylvester SR (1988) Molecular biology of the Sertoli cell. Oxf. Rev. Reprod. Biol. 10, 124–161. [PubMed] [Google Scholar]
  • 10. Bitgood MJ, Shen L, McMahon AP (1996) Sertoli cell signaling by Desert hedgehog regulates the male germline. Curr. Biol. 6, 298–304. [DOI] [PubMed] [Google Scholar]
  • 11. Wang MZ, Jin P, Bumcrot DA, Marigo V, McMahon AP, Wang EA et al. (1995) Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat. Med. 1, 1184–1188. [DOI] [PubMed] [Google Scholar]
  • 12. Sanberg PR, Borlongan CV, Othberg AI, Saporta S, Freeman TB, Cameron DF (1997) Testis‐derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med. 3, 1129–1132. [DOI] [PubMed] [Google Scholar]
  • 13. Cameron DF, Othberg AI, Borlongan CV, Rashed S, Anton A, Saporta S et al. (1997) Post‐thaw viability and functionality of cryopreserved rat fetal brain cells cocultured with Sertoli cells. Cell Transplant. 6, 185–189. [DOI] [PubMed] [Google Scholar]
  • 14. Marcel M, Daadi L, Weiss S (1999) Generation of tyrosine hydroxylase‐producing neurons from precursors of the embryonic and adult forebrain. J. Neurosci. 19, 4484–4497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Othberg AI, Willing AE, Cameron DF, Anton A, Saporta S, Freeman TB et al. (1998) Trophic effect of porcine Sertoli cells on rat and human ventral mesencephalic cells and hNT neurons in vitro. Cell Transplant. 7, 157–164. [DOI] [PubMed] [Google Scholar]
  • 16. Cramer DV, Wu GD, Makowka L (1993) Pathogenesis of xenograft reactions in rodents and other small laboratory species. Transplant. Proc. 25, 2846–2847. [PubMed] [Google Scholar]
  • 17. Sanberg PR, Borlongan CV, Saporta S, Cameron DF (1996) Testis‐derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat. Biotechnol. 14, 1692–1695. [DOI] [PubMed] [Google Scholar]
  • 18. Shamekh R, EL‐Badri NS, Saporta S, Pascual C, Sanberg PR, Cameron DF (2006) Sertoli cells induce systemic donorspecific tolerance in xenogenic transplantation model. Cell Transplant. 15, 45–53. [DOI] [PubMed] [Google Scholar]
  • 19. Araneda D, Thomas FT, Ljung T, Cekada E, Pittman K (1995) The primacy of humoral antibody (complement‐dependent cytotoxicity and antibody‐dependent cellular cytotoxicity) in concordant xenograft rejection. Transplant. Proc. 27, 268–269. [PubMed] [Google Scholar]
  • 20. Brundin P, Castilho RF, Hansson O (2000) FK506 and Cyclosporin A enhance the survival of culture and grafted rat embryonic dopamine neurons. Exp. Neurol. 164, 94–101. [DOI] [PubMed] [Google Scholar]
  • 21. Suarez‐Pinzon W, Korbutt GS, Power R, Hooton J, Rajotte RV, Rabinovitch A (2000) Testicular Sertoli cells protect islet beta‐cells from autoimmune destruction in NOD mice by a transforming growth factor‐beta1‐dependent mechanism. Diabetes 49, 1810–1818. [DOI] [PubMed] [Google Scholar]
  • 22. Willing AE, Othberg AI, Saporta S, Anton A, Sinibaldi S, Poulos SG et al. (1999a) Sertoli cells enhance the survival of co‐transplanted dopamine neurons. Brain Res. 822, 246–250. [DOI] [PubMed] [Google Scholar]
  • 23. Willing AE, Sudberry JJ, Othberg AI, Saporta S, Poulos SG, Cameron DF et al. (1999b) Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum. Brain Res. Bull. 48, 441–444. [DOI] [PubMed] [Google Scholar]
  • 24. Martin I, Wendt D, Heberer M (2004) The role of bioreactors in tissue engineering. Trends Biotechnol. 22, 80–86. [DOI] [PubMed] [Google Scholar]
  • 25. Doverskog M, Ljunggren J, Ohman L, Haggstrom L (1997) Physiology of cultures animal cells. J. Biotechnol. 59, 103–115. [DOI] [PubMed] [Google Scholar]
  • 26. G`odia F, Cair′o JJ (2002) Metabolic engineering of animal cells. Bioprocess Biosyst. Eng. 24, 289–298. [Google Scholar]
  • 27. Tsao YS, Cardoso AG, Condon RGG et al. (2005) Monitoring Chinese hamster ovary cell culture by the analysis of glucose and lactate metabolism. J. Biotechnol. 118, 316–327. [DOI] [PubMed] [Google Scholar]
  • 28. Abranches E, Bekman E, Henrique D et al. (2007) Expansion of mouse embryonic stem cells on microcarriers. Biotechnol. Bioeng. 96, 1211–1221. [DOI] [PubMed] [Google Scholar]
  • 29. Hassell T, Gleave S, Butler M (1991) Growth inhibition in animal cell culture. The effect of lactate and ammonia. Appl. Biochem. Biotechnol. 30, 29–41. [DOI] [PubMed] [Google Scholar]
  • 30. Lao MS, Toth D (1997) Effects of ammonium and lactate on growth and metabolism of a recombinant Chinese hamster ovary cell culture. Biotechnol. Prog. 13, 688–691. [DOI] [PubMed] [Google Scholar]
  • 31. Schneider M, Marison IW, Stockar UV (1996) The importance of ammonia in mammalian cell culture. J. Biotechnol. 46, 161–185. [DOI] [PubMed] [Google Scholar]
  • 32. Fernandes AM, Fernandes TG, Diogo MM et al. (2007) Mouse embryonic stem cell expansion in a microcarrier‐based stirred culture system. J. Biotechnol. 132, 227–236. [DOI] [PubMed] [Google Scholar]
  • 33. Genzel Y, Behrendt I, K¨onig S et al. (2004) Metabolism of MDCK cells during cell growth and influenza virus production in large‐scale microcarrier culture. Vaccine 22, 2202–2208. [DOI] [PubMed] [Google Scholar]
  • 34. Steinberger A, Heindel JJ, Lindsey JN, Elkington JS, Sanborn BM, Steinberger E (1975) Isolation and culture of FSH responsive Sertoli cells. Endocr. Res. 2, 261–272. [DOI] [PubMed] [Google Scholar]
  • 35. Daadi  , Samuel W (1999) Generation of tyrosine hydroxylase‐producing neurons from precursors of the embryonic and adult forebrain. J. Neurosci. 19, 4484–4497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Cherry RS, Kwon KY (1990) Transient shear stresses on a suspension cell in turbulence. Biotechnol. Bioeng. 36, 563–571. [DOI] [PubMed] [Google Scholar]
  • 37. Sen A, Kallos MS, Behie LA (2002a) Expansion of mammalian neural stem cells in bioreactors: effect of power input and medium viscosity. Dev. Brain Res. 134, 103–113. [DOI] [PubMed] [Google Scholar]
  • 38. Youn BS, Sen A, Kallos MS, Behie LA, Girgis‐Gabardo A, Kurpios N et al. (2005) Large‐scale expansion of mammary epithelial stem cell aggregates in suspension bioreactors. Biotechnol. Prog. 21, 984–993. [DOI] [PubMed] [Google Scholar]
  • 39. Koller M, Bradley M, Palsson B (1995) Growth factor consumption and production in perfusion cultures of human bone marrow correlate with specific cell production. Exp. Hematol. 23, 1275–1283. [PubMed] [Google Scholar]
  • 40. Nilsson K (1989) Microcarrier cell culture. Biotechnol. Genet. Eng. Rev. 6, 403–439. [PubMed] [Google Scholar]
  • 41. Ozturk SS, Riley MR, Palsson BO (1992) Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production. Biotechnol. Bioeng. 39, 418–431. [DOI] [PubMed] [Google Scholar]
  • 42. Patel SD, Papoutsakis ET, Winter JN, Miller WM (2000) The lactate issue revisited: novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures. Biotechnol. Prog. 16, 885–892. [DOI] [PubMed] [Google Scholar]
  • 43. Santos SS, Fonseca LL, Monteiro MAR, Carrondo MJT, Alves PM (2005) Culturing primary brain astrocytes under a fully controlled environment in a novel bioreactor. J. Neurosci. Res. 79, 26–32. [DOI] [PubMed] [Google Scholar]
  • 44. Yokomizo AY, Antoniazzi MM, Galdino PL (2004) Rabier virus production in high Vero cell density cultures in macroporous microcarriers. Biotechnol. Bioeng. 85, 506–515. [DOI] [PubMed] [Google Scholar]
  • 45. Fok EYL, Zandstra PW (2005) Shear‐controlled single‐step mouse embryonic stem cell expansion and embryoid body‐based differentiation. Stem Cells 23, 1333–1342. [DOI] [PubMed] [Google Scholar]
  • 46. Zandstra P, Eaves C, Piret J (1994) Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells. J. Biotechnol. 12, 909–914. [DOI] [PubMed] [Google Scholar]
  • 47. Pierson B, Europa A, Hu W, Miller J (1996) Production of human natural killer cells for adoptive immunotherapy using a computer‐controlled stirred‐tank bioreactor. J. Hematother. 5, 475–483. [DOI] [PubMed] [Google Scholar]
  • 48. Collins PC, Miller WM, Papoutsakis ET (1998a) Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. Biotechnol. Bioeng. 59, 534–543. [DOI] [PubMed] [Google Scholar]
  • 49. Collins PC, Nielsen LK, Patel SD, Papoutsakis ET, Miller WM (1998b) Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred‐tank bioreactor system. Biotechnol. Prog. 14, 466–472. [DOI] [PubMed] [Google Scholar]
  • 50. Sen A, Kallos MS, Behie LA (2002b) Passaging protocols for mammalian neural stem cells in suspension bioreactors. Biotechnol. Prog. 18, 337–345. [DOI] [PubMed] [Google Scholar]
  • 51. Gerecht‐Nir S, Cohen S, Itskovitz‐Eldor J (2004) Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol. Bioeng. 86, 492–502. [DOI] [PubMed] [Google Scholar]
  • 52. Wartenberg M, Donmez F, Ling FC, Acker H, Hescheler J, Sauer H (2001) Tumor‐induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J. 15, 995–1005. [DOI] [PubMed] [Google Scholar]
  • 53. Moreira JL, Alves PM, Aunins JG, Carrondo MJT (1995) Hydrodynamic effects on BHK cells grown as suspended natural aggregates. Biotechnol. Bioeng. 46, 351–360. [DOI] [PubMed] [Google Scholar]
  • 54. Altamiramo C, Paredes C, Cairo JJ, Godia F (2000) Improvement of CHO cell culture medium formulation: Simultaneous substitution of glucose and glutamine. Biotechnol. Prog. 16, 69–75. [DOI] [PubMed] [Google Scholar]
  • 55. Glacken MW (1988) Catabotic control of mammalian cell culture. J. Biotechnol. 6, 1041–1050. [Google Scholar]
  • 56. Yang Y, Rossi FMV, Putnins EE (2007) Ex vivo expansion of rat bone marrow mesenchymal stromal cells in microcarrier beads in spin culture. Biomaterials 28, 3110–3120. [DOI] [PubMed] [Google Scholar]
  • 57. Raffoul T, Swiech K, Arantes MK et al. (2005) Performance evaluation of CHO‐K1 cell in culture medium supplemented with hemolymph. Braz. Arch. Biol. Technol. 48, 85–95. [Google Scholar]

Articles from Cell Proliferation are provided here courtesy of Wiley

RESOURCES